Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions.

Villarino A, Laurence A, Robinson GW, Bonelli M, Dema B, Afzali B, Shih HY, Sun HW, Brooks SR, Hennighausen L, Kanno Y, O'Shea JJ.

Elife. 2016 Mar 21;5. pii: e08384. doi: 10.7554/eLife.08384.

2.

Dual-Specificity Phosphatase 4 Regulates STAT5 Protein Stability and Helper T Cell Polarization.

Hsiao WY, Lin YC, Liao FH, Chan YC, Huang CY.

PLoS One. 2015 Dec 28;10(12):e0145880. doi: 10.1371/journal.pone.0145880. eCollection 2015.

3.

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.

Fenwick PS, Macedo P, Kilty IC, Barnes PJ, Donnelly LE.

PLoS One. 2015 Jun 19;10(6):e0128757. doi: 10.1371/journal.pone.0128757. eCollection 2015.

4.

IFN-α/β receptor signaling promotes regulatory T cell development and function under stress conditions.

Metidji A, Rieder SA, Glass DD, Cremer I, Punkosdy GA, Shevach EM.

J Immunol. 2015 May 1;194(9):4265-76. doi: 10.4049/jimmunol.1500036. Epub 2015 Mar 20.

5.

PDZRN3/LNX3 is a novel target of human papillomavirus type 16 (HPV-16) and HPV-18 E6.

Thomas M, Banks L.

J Virol. 2015 Jan 15;89(2):1439-44. doi: 10.1128/JVI.01743-14. Epub 2014 Oct 29.

6.

JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Jay J, Hammer A, Nestor-Kalinoski A, Diakonova M.

Mol Cell Biol. 2015 Jan;35(1):111-31. doi: 10.1128/MCB.01138-14. Epub 2014 Oct 20.

7.

Differential expression profiling of spleen microRNAs in response to two distinct type II interferons in Tetraodon nigroviridis.

Yi S, Lu D, Peng W, Wang T, Zhang Y, Lin H.

PLoS One. 2014 May 6;9(5):e96336. doi: 10.1371/journal.pone.0096336. eCollection 2014.

8.

STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.

Kopp KL, Ralfkiaer U, Gjerdrum LM, Helvad R, Pedersen IH, Litman T, Jønson L, Hagedorn PH, Krejsgaard T, Gniadecki R, Bonefeld CM, Skov L, Geisler C, Wasik MA, Ralfkiaer E, Ødum N, Woetmann A.

Cell Cycle. 2013 Jun 15;12(12):1939-47. doi: 10.4161/cc.24987. Epub 2013 May 15.

9.

Major differences in the responses of primary human leukocyte subsets to IFN-beta.

van Boxel-Dezaire AH, Zula JA, Xu Y, Ransohoff RM, Jacobberger JW, Stark GR.

J Immunol. 2010 Nov 15;185(10):5888-99. doi: 10.4049/jimmunol.0902314. Epub 2010 Oct 18.

10.

Stat1 nuclear translocation by nucleolin upon monocyte differentiation.

Jerke U, Tkachuk S, Kiyan J, Stepanova V, Kusch A, Hinz M, Dietz R, Haller H, Fuhrman B, Dumler I.

PLoS One. 2009 Dec 14;4(12):e8302. doi: 10.1371/journal.pone.0008302.

11.

Long-term pegylated interferon-alpha and its potential in the treatment of melanoma.

Dummer R, Mangana J.

Biologics. 2009;3:169-82. Epub 2009 Jul 13.

12.

Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling.

Burdeinick-Kerr R, Govindarajan D, Griffin DE.

J Virol. 2009 Apr;83(8):3429-35. doi: 10.1128/JVI.02381-08. Epub 2009 Jan 28.

13.

In vivo identification of novel STAT5 target genes.

Basham B, Sathe M, Grein J, McClanahan T, D'Andrea A, Lees E, Rascle A.

Nucleic Acids Res. 2008 Jun;36(11):3802-18. doi: 10.1093/nar/gkn271. Epub 2008 May 20.

14.

Stimulated plasmacytoid dendritic cells impair human T-cell development.

Schmidlin H, Dontje W, Groot F, Ligthart SJ, Colantonio AD, Oud ME, Schilder-Tol EJ, Spaargaren M, Spits H, Uittenbogaart CH, Blom B.

Blood. 2006 Dec 1;108(12):3792-800. Epub 2006 Aug 17.

15.

STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA.

Benitah SA, Valerón PF, Rui H, Lacal JC.

Mol Biol Cell. 2003 Jan;14(1):40-53.

16.

Antiviral actions of interferons.

Samuel CE.

Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents. Review.

17.
18.

Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling.

Zhang S, Fukuda S, Lee Y, Hangoc G, Cooper S, Spolski R, Leonard WJ, Broxmeyer HE.

J Exp Med. 2000 Sep 4;192(5):719-28.

Supplemental Content

Support Center